Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute
API

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

PRE-CANCER DIAGNOSIS, LLC — Funding, Investors & Profile — Capbase

← All companies

Compare History

PRE-CANCER DIAGNOSIS, LLC

Private

Won a federal SBIR/STTR research award from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: SJERDG9G5TH3

Founded: —Source: [GOV]
Headquarters: BELLE MEAD, New JerseySource: [GOV]
Country: United StatesSource: [GOV]
Headcount: 1Source: [GOV]

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

PRE-CANCER DIAGNOSIS, LLC has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $398,738 in 2024. These are non-dilutive federal research grants, not equity financing. The company is based in BELLE MEAD, New Jersey.

Funding rounds

1 rounds

1 round · latest STTR Phase I award (HHS), Sep 2024

Investors

No investors recorded yet for PRE-CANCER DIAGNOSIS, LLC.

Add an investor

People

Leadership

ZHONGREN ZHOUPrincipal investigatorSince 2024Source: [GOV]

Acquisitions

PRE-CANCER DIAGNOSIS, LLC has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for PRE-CANCER DIAGNOSIS, LLC.

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Stage

Seed

Sector

Healthcare